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Abstract
Background: Lymphoma survivors commonly report ongoing complaints including fatigue, pain, depression and
decreased quality of life (QoL) following treatment. Although evidence suggests that both relaxation and exercise
can significantly improve such symptoms, there is no consensus on which intervention is more effective. This paper
presents the REIL (Relaxation and Exercise In Lymphoma) Study protocol. The REIL study aims to compare the effect
of two home-based interventions – relaxation and exercise – on QoL in lymphoma survivors.
Methods: Eligible participants (n = 36) will be randomised to a relaxation or exercise programme to perform at least
three times per week. The primary outcome measure is QoL, assessed by the European Organisation for Research and
Treatment of Cancer QoL Questionnaire Core 30 (EORTC QLQ-C30). Secondary outcome measures include body
composition, cardiovascular status, pulmonary function, grip strength, functional exercise capacity (six minute walk
test), well-being assessed by the FACT-Lym questionnaire, and psychological status assessed by the Hospital Anxiety
and Depression Scale. Total duration of the study will be twelve weeks and outcome measures will be assessed at
baseline, six weeks and at the end of the study.
Discussion: It is anticipated that results from this preliminary study will begin to highlight effective pathways to
improve QoL following chemotherapy for this population. This will better inform healthcare professionals to optimise
QoL of lymphoma patients, and enable a smooth transition from being a cancer patient to survivor.
Trial registration: The REIL study has been registered on a publicly accessible database, ClinicalTrials.gov, Registration
Number: NCT02272751, October 2014.
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Quality of life
Background
Significant improvements have been made in the survival
rates in cancer patients due to earlier detection and ad-
vances in treatment. Although initial research in the
field of cancer survivorship focused on tumours such as
breast and prostate, dramatic advances in haematological
malignancies have also led to increased survival [1], but
at a cost of increasing complications. Like survivors of
other cancers, lymphoma survivors are at an increased
risk of morbidity and adverse effects due to disease and
treatment exposures. Commonly reported long-term and
late effects of treatment in lymphoma survivors include
both physical and psychosocial symptoms such as fa-
tigue, pain, muscle weakness, neuropathies, depression,
anxiety and decreased self-esteem; as well as decreased
function and quality of life (QoL) [1–3]. Hence there has
been a call for further research to address the ongoing
needs of lymphoma survivors [1].
When medical treatment is completed successfully
and the patient is in clinical remission, the close support
from medical staff is usually reduced and the patient is
expected to return to ‘normal life’. This transition how-
ever does not always occur smoothly and studies have
highlighted that post-treatment survivors at this
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transition phase often feel unprepared and uninformed
[1, 3]. Survivors at this phase are sometimes in need of
further support and advice on how to progress activity,
manage ongoing symptoms and return to pre-morbid
status and often do not receive this [2, 3]. There are cur-
rently no recommended care pathways for lymphoma
patients in remission following treatment, despite the
fact that this transition period shortly after treatment
has been highlighted to be particularly difficult [4].
This lack of care pathways has been highlighted by the
government in the United Kingdom (UK). The National
Cancer Survivorship Initiative (NCSI) was launched in
2008 and calls for research into the development of
pathways for cancer survivors [5], recommending holis-
tic assessment and personalised care-planning, emphasis
on the use of patient-reported outcome measures and a
shift towards self-management [6].
Self-management in cancer survivorship has been de-
fined as ‘awareness and active participation by the per-
son in their recovery, recuperation and rehabilitation, to
minimise the consequences of treatment, and promote
survival, health and well-being” [7]. Increasing numbers
of survivors together with limited healthcare resources
has led to a focus on self-management as an important
approach for cancer survivors. Furthermore, self-man-
agement can empower cancer patients, increase their
confidence to manage problems associated with disease
and treatment, and enhance QoL [8].
Literature indicates that interventions such as relax-
ation and exercise both have a positive impact on QoL
of cancer survivors [9–12]. It has been demonstrated
that exercise interventions have a positive impact on
physical and psychological factors related to QoL such
as peak oxygen consumption, physical functioning, fa-
tigue, self-esteem and social functioning; as well as over-
all QoL of cancer patients and survivors [9, 10]. Studies
on relaxation interventions including mindfulness-based
stress reduction and progressive muscular relaxation
have also demonstrated significant positive impact on
physical and psychological symptoms such as fatigue,
pain, anxiety and depression, as well as on QoL in can-
cer survivors [10–12]. Hence both relaxation and exer-
cise interventions are recommended by organisations
providing expert advice and support to cancer patients
and survivors such as Lymphoma Action [13] and Mac-
millan Cancer Support [14].
However in the majority of trials studying the effects
of relaxation or exercise on cancer survivors, the benefits
have only been relative to a control group; and to rule
out potential placebo effects future studies need to spe-
cify more rigorous comparison conditions, for instance a
control intervention with similar elements that may in-
fluence outcome such as attention from study personnel
or time spent on the procedure [15, 16]. Hence there
has been a call for further studies to move beyond wait-
list control groups and to compare with active control
or other empirically supported interventions [15, 16], for
instance relaxation to exercise. As a result, there have
been studies and study protocols looking at comparison
of two interventions in cancer survivors, but the majority
of these have focused on breast cancer [17, 18] and au-
thors have called for future research to focus on other
survivor groups, including haematologic cancer sites [1,
19].
The REIL study aims to address some of these issues
highlighted by studying a sample of lymphoma survivors
post-chemotherapy, supporting patients during the tran-
sition phase, comparison of two interventions, use of pa-
tient-reported outcome measures and emphasis on self-
management. Results from this preliminary study would
provide an indication of efficacy of interventions, and
with the findings from the REIL study we aim to build
towards the development of evidence-based practice
guidelines for lymphoma survivors.
This paper presents the REIL study protocol using
SPIRIT 2013 guidelines [20].
Aims
The primary aim of the REIL Study is to compare the ef-
fect of two interventions – relaxation and exercise – on
QoL in a sample of lymphoma patients in remission
post-chemotherapy. The null hypothesis is that there is
no difference in QoL between the relaxation and exer-
cise groups post-intervention.
Secondary aims are to investigate the effects of the
two interventions on body composition, cardiovascular
status, pulmonary function, muscle strength, functional
exercise capacity, well-being and psychological status;
and explore perceptions about participation in the post-
treatment intervention programme.
Methods
Study design
The REIL study is a prospective, randomised, clinical
intervention trial. Participants will be randomised to ex-
ercise or relaxation intervention. Participants will be
assessed at baseline prior to commencing the interven-
tion programme, at six weeks, and at the end of the
twelve week intervention.
Ethical approval
The REIL study has received ethical approval from Cam-
den and Islington National Research Ethics Service (13/
LO/1327), who are the responsible for approval of final
protocol as well as any modifications or amendments.
Local site approval from St. George’s Hospital Joint Re-
search and Enterprise Office (JREO) has also been ob-
tained (13.0108). The JREO is an independent office
Hathiramani et al. BMC Sports Science, Medicine and Rehabilitation           (2019) 11:17 Page 2 of 9
providing external review and monitoring of any re-
search undertaken at St. George’s NHS Trust in order to
maintain clinical research governance guidelines and
standards.
The study has been registered on a publicly accessible
database, ClinicalTrials.gov, NCT02272751.
Recruitment
Participants will be recruited from a single specialist
clinical setting – the Haematology-Oncology Out-Pa-
tient (HOOP) Clinic at St George’s Hospital, London.
Assessment for eligibility, recruitment, medical screening
and obtaining of informed consent will be carried out by
the patients’ medical consultant (RP). In order to en-
courage participant enrolment, potential participants will
be introduced to the principal investigator (SH) who will
explain about the study, answer questions and provide
with the written participant information sheet to take
away and read before making a decision.
Eligibility criteria
Inclusion criteria include patients with histologically
confirmed lymphoma in remission post–chemotherapy,
chemotherapy treatment completed within the last six
weeks, age 18 years or older, able to give informed con-
sent, good performance status (assessed by the Eastern
Cooperative Oncology Group {ECOG} status 0–2) [21]
and medically able to carry out an exercise training
programme. Patients with active disease, unstable angina
or unexplained electrocardiogram, poor performance
status (ECOG status 3 or more), pregnancy, difficulty
breathing at rest, persistent cough, fever or illness, or
any cognitive impairment limiting ability to give in-
formed consent or complete QoL questionnaires will be
excluded. Written informed consent will be obtained
from all individual participants included in the study.
Sample size
Sample size was calculated to determine clinically rele-
vant effects on the primary outcome measure, the Euro-
pean Organisation for Research and Treatment of
Cancer – QoL core questionnaire (EORTC QLQ-C30,
version 3.0). A minimally important difference of 5 to 10
points is generally accepted as clinically meaningful [22],
and calculations were based on comparison of means be-
tween two groups. Assuming a two-sided significance
level level (α) of 0.05, power of 80% (ß = 0.20) and stand-
ard deviation from EORTC website reference values
[23], it was determined that a sample of minimum 46
participants will be required to detect a significant
change in the EORTC summary score, 23 in each inter-
vention group.
Randomisation
A random allocation list will be prepared by the depart-
ment statistician, generated using GraphPad randomisa-
tion software (GraphPad Prism version 6.04 for
Windows, GraphPad software, CA). On entry into the
study each participant will be assigned an anonymous ID
number and each number will be allocated an interven-
tion (exercise or relaxation) on the list. As all assessment
sessions will be carried out by the single principal inves-
tigator (SH), it will not be possible to blind the investiga-
tor to intervention. Also due to the nature of the
intervention participants cannot be blinded to group
allocation.
Flow of participants in the study is shown in Fig. 1.
Interventions
Interventions for this study are reported using the tem-
plate for intervention description and replication
(TIDieR) checklist and guide [24].
For both groups, advice, instruction, demonstration
and practice will be carried out at baseline. This will be
delivered by the principal investigator SH, an experi-
enced physiotherapist with a special interest and experi-
ence in oncology. Participants will be able to contact SH
by telephone in between sessions if additional support is
required. All participants will be advised on potential ad-
verse events and what to report including pain, fatigue,
muscle soreness, lymphoedema, nausea, dyspnoea, dizzi-
ness, tachycardia and cramp. A logbook will be provided
to all participants to encourage adherence and document
self-reported participation levels, intervention type car-
ried out, frequency, intensity, duration and any adverse
events.
Exercise intervention
While there are no guidelines for the delivery of exercise
in cancer survivors, it is recommended to follow the
guidelines for general UK population [25]. Hence partici-
pants randomised to the exercise intervention in this
study will be advised to carry out the programme for at
least 50 min three times per week.
The exercise programme includes elements of aerobic,
upper and lower limb resistance training, core stability
and stretches and is designed to be performed independ-
ently at home. For the aerobic component, participants
will be advised to walk indoors or outdoors for a mini-
mum of 30min and to aim for moderate intensity as rec-
ommended by the Borg Rate of Perceived Exertion
(RPE) scale [26]. Where unable to maintain moderate in-
tensity due to fatigue, weakness or other complaints,
participants will be advised to aim for moderate intensity
aerobic exercise for any duration of time able, and to
gradually increase over the next few weeks aiming to
build up to 150 min over one week. They will be taught
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resistance exercises for the major upper and lower limb
muscles using body weight or TheraBand™ isometric re-
sistance bands to carry out following aerobic activity.
The resistance training follows American College of
Sports Medicine (ACSM) guidelines [27], and partici-
pants will be advised to carry out three sets of each exer-
cise for 8–12 repetitions. They will also be taught
stretches for upper and lower limb muscles, and core
abdominal exercises in supine. Participants will be
also be provided with written instruction, leaflet with
photographs and advice sheet. Similar programmes in-
corporating aerobic, resistance and flexibility training
three times a week over a twelve week period have
been used with good results in improving QoL in
cancer survivors [9].
Relaxation intervention
The relaxation intervention consists of a bed- or chair-
based program, developed based on the literature on
mindfulness-based interventions in cancer survivors
[10–12]. An audio CD was produced to guide partici-
pants through relaxation techniques incorporating mind-
fulness meditation, breathing exercises, guided
visualisation and progressive muscle relaxation. Here
also participants will be advised to carry out the
programme for 50 min three times a week. Participants
will also be provided with written information on relax-
ation and tips on how to incorporate into daily life. Par-
ticipants in this group will not be advised to perform
any exercise outside of their normal habits, nor asked to
avoid activity.
Fig. 1 Flow of participants in the REIL Study. CONSORT flow diagram demonstrating participant flow through each phase of the randomised
controlled trial (enrolment, intervention allocation, follow-up and data analysis)
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Participants will be followed-up at six weeks, midway
through the programme. At this stage all assessments
will be repeated, any change noted and they will be ad-
vised on how to modify the programme (relaxation or
exercise) as appropriate. Once participants have com-
pleted twelve weeks of their intervention, they will be
provided with resources of the other intervention group,
for their information or to carry out as desired, in ac-
cordance with the Declaration of Helsinki.
Outcome measures
All outcome measures will be assessed at baseline prior
to commencing intervention, midway (six weeks) and on
completion of intervention programme (twelve weeks).
Outcome measures, instruments and guidelines used
and time assessed are summarised in Table 1. At base-
line, patient demographics including gender, age, social
history and medical history will be recorded.
Quality of life
The primary outcome measure is QoL, assessed by the
EORTC QLQ-C30. This self-reported questionnaire has
been demonstrated to be a valid and reliable tool, takes
approximately eleven minutes to complete and most
subjects require no assistance [28]. This has been used
extensively in cancer survivorship research, and also spe-
cifically with lymphoma patients [29]. The EORTC
QLQ-C30 consists of thirty items. Each question is
answered on a four-point scale and scores are derived
according to the EORTC scoring manual [30].
Body composition
Due to the illness itself and treatment and side-effects
(including steroid use, loss of appetite, nausea and
vomiting), lymphoma patients may experience a fluctu-
ation in weight and body fat percentage during the dur-
ation of their treatment. Therefore body composition
will be assessed using a bioelectrical impedance analyser
(Tanita BC-418) to monitor whether it will stabilise to
within the desired range. Participants’ standing stature
will be measured using a stadiometer (SECA, Germany).
Height measured will be inserted into the body compos-
ition analyser to obtain weight, body mass index (BMI),
and body fat percentage. Participants will be measured
without footwear and in light clothing using the same
equipment each time.
Cardiovascular and pulmonary status
Resting Blood Pressure (BP) and Heart Rate (HR) will be
assessed using an electronic BP monitor (Omron M10-
IT, Japan) and finger pulse oximeter (Solaris S10A,
China) in sitting. In addition, measures of pulmonary
capacity and function will be assessed using a hand-held
microspirometer (Micro 1 Medical Microspirometer,
England) following British Thoracic Society guidelines
[31]. Forced expiratory volume in one second (FEV1),
Table 1 Primary and Secondary Outcome Measures
Outcome measured Instrument Guidelines When assessed
Baseline Midway
6 weeks
End of
intervention
12 weeks
Primary outcome
Quality of Life EORTC QLQ-C30 Self-reported Questionnaire ☑ ☑ ☑
Secondary outcomes
Body Composition Height, Weight, Bioimpedance analysis –
BMI, Body Fat % - TANITA BC-418 Body
Composition Analyzer
Same investigator and equipment,
time of day and clothing kept
similar where possible
☑ ☑ ☑
Cardiovascular status – Resting
BP, HR, SpO2
Omron M10-IT electronic BP monitor,
Solaris Finger Pulse Oximeter S10A
☑ ☑ ☑
Pulmonary Function – FEV1, FVC,
FER, PEF
Hand-held Micro 1 Medical
Microspirometer
British Thoracic Society, 2013 ☑ ☑ ☑
Muscle Strength – Grip Strength Jamar® Hydraulic Hand Dynamometer American College of Sports
Medicine, 2014
☑ ☑ ☑
Functional Exercise Capacity Six Minute Walk Test American Thoracic Society, 2002 ☑ ☑ ☑
Physical Well-being, Social/Family
Well-being, Emotional Well-being,
Functional Well-being
FACT-Lym Self-reported Questionnaire
Anxiety and Depression HADS ☑ ☑ ☑
Feelings and Perceptions about
participating in programme
End of Study Questionnaire Open-ended Questionnaire mailed
to participants’ home
☑
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forced vital capacity (FVC), forced expiratory ratio (FER)
and expiratory peak flow (PEF) will be recorded.
Muscle strength
Grip strength is a good indication of global muscle
strength and assessment of grip is common method that
is used to assess general strength characteristics [32].
Here, isometric grip strength will be measured in kilo-
grams using an adjustable hand-held dynamometer
(Jamar® Hydraulic Hand Dynamometer, USA) with the
elbow flexed at 90 degrees and the forearm and wrist in
neutral position following standardised American Col-
lege of Sports Medicine (ACSM) guidelines [32].
Functional exercise capacity
Due to the variation in the population being studied in
terms of age, co-morbidity and physical ability, a sub-
maximal test was considered appropriate for this study.
The Six-Minute Walk Test (6MWT) is considered a
good indicator of functional ability and exercise capacity
and is a common outcome measure to evaluate progress
in rehabilitation programmes [33]. This test was chosen
as it can be undertaken in a clinical setting with ease,
takes a short duration of time to complete and appeared
appropriate for this sample of patients following chemo-
therapy who are generally deconditioned and fatigue
quickly. The 6MWT has been validated and used exten-
sively in a variety of patient populations, and has been
recommended for use in cancer patients also [34].
The 6MWT will be carried out following guidelines
recommended by the American Thoracic Society (ATS)
[33]. The test will be carried out in a 30m marked dis-
tance, and the total distance covered in 6 min will be re-
corded, as well as post-test Heart Rate and oxygen
saturation, RPE and Rate of Dyspnoea [26]. The test will
cease prior to 6 min if the patient chooses to stop or the
tester terminates testing (indications for terminating ex-
ercise as per the ATS guidelines include the following:
severe exhaustion or shortness of breath, wheezing, diz-
ziness, chest pain or muscle cramps) [33]. At no point
will the patient be encouraged to continue beyond the
level at which they wish to stop.
Well-being
The Functional Assessment of Chronic Illness Therapy
(FACIT) questionnaires have been validated in studies of
cancer management and are designed to encompass a
range of psychosocial factors [35]. Like the EORTC
QLQ-C30, these questionnaires are also a patient re-
ported measure of QoL. However these questionnaires
focus on aspects of well-being including physical, social,
emotional and functional well-being subscales. Here, the
lymphoma-specific scale (FACT-Lym) will be used
(comprising the general or FACT-G questionnaire plus a
lymphoma subscale. The FACT-Lym has good internal
consistency and validity [35]. All questions are answered
on a five-point scale and scoring guidelines are recom-
mended together with the questionnaire [36].
Psychological status
The Hospital Anxiety and Depression Scale (HADS) is a
valid tool for assessing the severity of anxiety disorders
and depression in various populations including psychi-
atric, primary care patients and the general population
[37]. The HADS is also recommended in cancer settings
[38]. Questions are answered using a four-point scale
and higher scores represent higher levels of anxiety and
depression.
End of study questionnaire
During their final assessment at twelve weeks, partici-
pants will be invited to complete the end of study ques-
tionnaire. The open questions aim to explore their
thoughts and feelings about the intervention
programme, and to analyse their views on their particu-
lar intervention including preferences, perceived advan-
tages and disadvantages and reasons for participation
and adherence.
Data analysis
Data will be entered into the Microsoft Excel (2013)
database by SH and analysed by all authors using the
IBM SPSS version 22 (SPSS, Inc., Chicago, IL) statis-
tical software package. The intent-to-treat principle
will be applied and the significance level will be set at
0.05. Descriptive statistics will be used to present
baseline demographic characteristics. To compare dif-
ference in the primary outcome measure, QoL score
between the two groups post-intervention, ANCOVA
(analysis of covariance) will be used, with pre-test
values as covariate to adjust for any baseline differ-
ences. Data will be analysed to check fit for
ANCOVA assumptions. Post-hoc paired-samples t-
tests for pre-post intervention will be tested within
groups with Bonferroni corrections. Missing data will
be treated as recommended by scoring guidelines of
questionnaires [24, 30]. These analyses will be re-
peated for secondary outcome measures, providing
data fit normal distribution and other assumptions for
ANCOVA. The influence of potential confounding
factors such as age, gender, number of co-morbidities
and ECOG status will be explored using correlation
analyses. Adherence and drop-out rates will also be
analysed. Qualitative data from the end of study ques-
tionnaire will be analysed for codes and themes using
qualitative content analysis [39].
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Discussion
A large proportion of lymphoma survivors continue to
experience unmet needs following treatment [1–3].
Long-term and late effects are often overlooked, and
survivors do not routinely receive advice or interventions
to target these and maximise well-being [40]. Previous
studies have supported the use of both relaxation and
exercise interventions to treat physical and psychosocial
complaints of cancer survivors [9–12]. No trial to date
has compared efficacy of these two interventions in
lymphoma survivors.
The REIL study aims to study a sample of lymph-
oma survivors shortly post-chemotherapy, and com-
pare the effectiveness of relaxation and exercise on
improving QoL. This study was developed to address
some issues highlighted in survivorship literature in-
cluding focus on survivors of cancers other than
breast or prostate, emphasis on the transition phase
immediately following treatment, addressing physical,
psychological and social needs of lymphoma survivors,
use of patient-reported outcome measures, self-man-
agement, and moving from control groups to com-
parison between two interventions.
In this study lymphoma patients in remission will
be recruited within six weeks of their last chemother-
apy session. Patients during this early phase of sur-
vivorship who have completed initial cancer treatment
have been relatively neglected [19], and this period
immediately following treatment has been identified
as a key time to address side effects of treatment and
facilitate return to pre-morbid health [41]. Studies on
cancer survivors have indicated that they would prefer
to begin an exercise programme immediately or soon
after treatment [42], and at this point the focus can
move from the disease and treatment to ‘moving on’
to the next phase of life [43].
While the additional psychosocial benefits of super-
vised group classes for cancer survivors have been recog-
nised [44], the need for a shift towards self-management
in cancer survivorship has been highlighted [6, 7]. Here
participants are supported to self-manage in a variety of
ways, but the onus will be on them to initiate contact
with the healthcare professionals for additional support
when needed [7, 8]. Both the relaxation and exercise
programmes in this study are designed to be performed
independently and participants will be supplied with re-
sources to allow convenient home-based performance,
including written instructions and advice. Participants
will be able to contact the investigator whenever re-
quired. This study will provide results including ad-
herence and drop-out rates that are more
generalizable to ‘real-world’ lymphoma survivors than
controlled clinic-based research. Home-exercise pro-
grammes also afford patients better scheduling
flexibility, familiar surroundings, family support and
reduced travel requirements [45].
It will not be possible to stratify participants by factors
such as age, gender, etc. during randomization due to
the small sample size. However, sample size was calcu-
lated using reference values (including standard devi-
ation) and power calculations recommended by the
EORTC reference manual [23]; similar trials on the ef-
fects of exercise in cancer patients have been carried out
with comparable sample sizes, and these were able to de-
tect significant results [9].
In addition to quantitative data from outcome mea-
sures, the end of study questionnaire will explore partici-
pants’ perceptions and feelings towards an intervention
programme post-chemotherapy. Such information will
highlight behaviours and patterns in this sample of
lymphoma survivors including reasons for participation,
adherence and non-adherence, and any preferences; it is
anticipated that this data will ultimately help in the pro-
motion of a healthy lifestyle in lymphoma and cancer
survivors.
The authors will aim to publish results from this study
to add to the evidence to inform healthcare professionals
on effective interventions to improve QoL of lymphoma
survivors.
Conclusion
It is well documented that lymphoma survivors commonly
suffer from consequences of treatment such as pain, fa-
tigue, decreased function, anxiety and depression which
have a negative impact on their quality of life. However,
there is no standardize care pathway recommended for
lymphoma survivors following chemotherapy.
The current proposed REIL study aims to determine
the more effective intervention of two in improving
QoL in lymphoma survivors. It is anticipated that re-
sults from this preliminary study will help build to-
wards the development of feasible and effective
practice guidelines to improve QoL of lymphoma sur-
vivors post-chemotherapy.
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